IMS Practical Insights in Novel Immune Therapies in Multiple Myeloma Series
Join us virtually on March 27 and April 10
The International Myeloma Society (IMS) is proud to announce webIMarS, a new webinar series co-hosted in partnership with local hematology societies.
These 90-minute webinars on Relapsed Refractory Multiple Myeloma will be led by local faculty and are designed for regional audiences. The goal of this series is to share updated knowledge in diagnosis, monitoring, and treatment of Plasma Cell malignancies with a focus on the local practice patterns.
Upcoming Webinars:
Wednesday February 12, 2025 with Myeloma Australia at 6:30 pm AEDT
Wednesday February 19, 2025 with the Japanese Society of Myeloma at 7:00 pm JST
These 90-minute webinars on Relapsed Refractory Multiple Myeloma will be led by local faculty and are designed for regional audiences. The goal of this series is to share updated knowledge in diagnosis, monitoring, and treatment of Plasma Cell malignancies with a focus on the local practice patterns.
Upcoming Webinars:
Wednesday February 12, 2025 with Myeloma Australia at 6:30 pm AEDT
Wednesday February 19, 2025 with the Japanese Society of Myeloma at 7:00 pm JST
Registration is complimentary.
Co-hosted with Myeloma Australia
Co-hosted with the Japanese Society of Myeloma
The International Myeloma Society gratefully acknowledges the support of our co-hosts
About the International Myeloma Society
The International Myeloma Society is a professional, scientific, and medical society established to
bring together clinical and experimental scientists involved in the study of myeloma.
The purpose of this society is to promote research, education, clinical studies (including diagnosis
and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical
investigators in the field along with physicians and other healthcare practitioners.
bring together clinical and experimental scientists involved in the study of myeloma.
The purpose of this society is to promote research, education, clinical studies (including diagnosis
and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical
investigators in the field along with physicians and other healthcare practitioners.